Fexofenadine Hydrochloride

Producers shown on SFDA

(Record date:12/10/2021）

Producers shown on EP

(Quoted from EP website；record date:12/10/2021）

Producer:Zhejiang Lepu Pharmaceutical Co., Ltd., established in 2001, is located in Jiaojiang block, Taizhou chemical API Industrial Park, Zhejiang Province. Covering an area of nearly 300 mu, the company is a core subsidiary of Lepu (Beijing) medical device company.

The company attaches great importance to product quality and has successively passed GMP certification and registration such as China nm-pa, US FDA, EU EDQM, Japan PMDA and Korea KFDA. Many varieties occupy a leading position in the world.

The company's marketing network covers five continents and has established partnerships with nearly 600 customers at home and abroad in more than 70 countries and regions. Many products lead the sales in the international market, among which the sales of main varieties of atorvastatin calcium account for more than 50% of the world.

Staff size:700-799 persons

Registered capital:RMB 160 million

Producer:Zhejiang Huahai Pharmaceutical Co., Ltd.was founded in 1989 and headquartered in Zhejiang, China. The company has nearly 7000 employees and more than 40 subsidiaries around the world (including China, the United States, Japan, Germany, etc.As a leading enterprise in the internationalization of Chinese medicine, Huahai pharmaceutical is the first pharmaceutical company in China to pass the FDA preparation quality certification and independently own the Anda document number. It is also the first Chinese pharmaceutical company to realize large-scale preparation sales in the United States. It has established China's pharmaceutical quality image in the world's high-end pharmaceutical market.

Staff size:About 7000 persons

Registered capital:RMB 1 billion 492 million

Producer:Hainan Sha Ting Ning Pharmaceutical Co., Ltd., founded in 2015, has four workshops that meet the requirements of drug production and pass GMP certification. All production raw materials of the company have obtained and passed the GMP certification of the State Food and drug administration.

Staff size:50-99 persons

Registered capital:RMB 10 million

Producer:Venturepharm (Hainan) Co., Ltd.,is a group providing outsourced production service management for global pharmaceutical enterprises, which is authorized and managed by venturepharm Group Inc.

With 7 advanced API and preparation production bases in Asia, the company provides comprehensive production outsourcing services for global pharmaceutical enterprises. Customers can obtain professional support and services from the early stage of product development to large-scale production. All production bases of vante have passed GMP certification, and two API production bases have passed FDA certification.

Staff size:100-199 persons

Registered capital:RMB 194 million 870 thousand and 600

Producer:Sichuan Xuhui Pharmaceutical Co., Ltd. was established in 2011, covering an area of 25346 square meters. The company has passed the new GMP certification of the State Food and Drug Administration on March 18, 2013. There are 10 approvals for API and chemical agents, including national class II new drugs fexofenadine hydrochloride tablets and amlexanol paste, National medical insurance new drugs cilostazol tablets and zomitriptan tablets.

Staff size:About 50 persons

Registered capital:RMB 30 million

Producer:Chizhou Dongsheng Pharmaceutical Co., Ltd. is a high-tech enterprise specializing in pharmaceutical and chemical research and production. It mainly produces chemical raw materials and pharmaceutical intermediates such as cephalosporin side chain, citalopram, pantoprazole sodium and zopiclone. Its products are well-known in domestic and foreign markets. In 2010, the company built a new GMP production plant to produce API such as fexofenadine hydrochloride, diammonium glycyrrhizinate and tiopronin.

Staff size:About 50 persons

Registered capital:RMB 6 million

Producer:Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Tianshili Pharmaceutical Group Co., Ltd. the company covers an area of 323 Mu and a construction area of about 87700 square meters. The company mainly produces chemical raw materials and oral solid preparations (tablets and capsules). The products mainly involve anti-tumor, cardiovascular, psychiatric and liver protecting drugs.

The company has a chemical API manufacturing platform (anti-tumor API and ordinary API) with an annual output of 300t, and a common solid preparation and anti-tumor solid preparation manufacturing platform with an annual output of 2.2 billion tablets (tablets). All dosage forms of the company have passed the new Chinese GMP certification, and the API has successively passed the EU GMP certification, South Korea GMP certification and Japan GMP certification. The company has also passed ISO14001 environmental management system certification, ISO9001 quality management system and OHSAS18001 occupational health and safety evaluation system certification.

Registered capital:RMB 66.86 million

The company has 28000 employees globally, fifth R & D centers were built around the globe and several subsidiaries were established in the US, EU, and Japan.

The company has 10 manufacturing facilities and most of them maintain USP, EUP, and JP. We are the first Chinese company that exported injections on a large scale to the US, EU, and Japan markets. All dosage forms of the company have passed the national GMP certification, and ifosfamide, etoposide, mesilar and tiotepa have passed the verification of FDA.

Staff size:About 30000 persons

Registered capital:RMB 6 billion 397 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978